Skip to main content
. 2023 May 10;13:7577. doi: 10.1038/s41598-023-34729-0

Figure 8.

Figure 8

Druglikeness analysis of the PeruNPDB and the reference datasets. (A) The similar distribution between FDA compounds and PeruNPDB. (B) Lipinski’s five rules from the FDA and PeruNPDB data sets. (C) Visual 3D representation of the chemical space as PCAs from the FDA and PeruNPDB data sets. (D) Representation t-SNE of FDA and PeruNPDB data sets.